D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 65 Citations 15,965 210 World Ranking 1359 National Ranking 80
Medicine D-index 80 Citations 23,986 360 World Ranking 9774 National Ranking 443

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Cancer

Jürgen K. Rockstroh mainly investigates Internal medicine, Immunology, Viral load, Hepatitis C and Acquired immunodeficiency syndrome. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Surgery. His research integrates issues of Liver disease, Epidemiology and Disease in his study of Immunology.

Clinical trial and Pharmacotherapy is closely connected to Integrase inhibitor in his research, which is encompassed under the umbrella topic of Viral load. His Hepatitis C research entails a greater understanding of Virology. Jürgen K. Rockstroh has included themes like Odds ratio, Hepatitis B, Stigma, Cohort study and Mental health in his Acquired immunodeficiency syndrome study.

His most cited work include:

  • Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel. (400 citations)
  • Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution (312 citations)
  • Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial (277 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Immunology, Virology, Hepatitis C and Hepatitis C virus. The study incorporates disciplines such as Gastroenterology, Ribavirin, Viral load and Coinfection in addition to Internal medicine. His work in Gastroenterology covers topics such as Regimen which are related to areas like Emtricitabine.

His Immunology study frequently draws connections to adjacent fields such as Acquired immunodeficiency syndrome. His Hepatitis C course of study focuses on Cohort and Cohort study. His studies deal with areas such as Fibrosis and Men who have sex with men as well as Hepatitis C virus.

He most often published in these fields:

  • Internal medicine (46.70%)
  • Immunology (33.01%)
  • Virology (29.10%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (46.70%)
  • Hepatitis C virus (19.80%)
  • Gastroenterology (17.60%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Hepatitis C virus, Gastroenterology, Virology and Hepatitis C. His Internal medicine study integrates concerns from other disciplines, such as Ribavirin, Men who have sex with men, Tenofovir alafenamide and Viral load. His Viral load study contributes to a more complete understanding of Immunology.

His work carried out in the field of Hepatitis C virus brings together such families of science as Fibrosis and Liver disease. Jürgen K. Rockstroh has included themes like Placebo and Fatty liver in his Gastroenterology study. Jürgen K. Rockstroh studied Hepatitis C and Transmission that intersect with Antiretroviral therapy.

Between 2016 and 2021, his most popular works were:

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study (249 citations)
  • Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial (115 citations)
  • Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission (111 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Cancer

Jürgen K. Rockstroh spends much of his time researching Internal medicine, Gastroenterology, Hepatitis C, Virology and Regimen. Specifically, his work in Internal medicine is concerned with the study of Adverse effect. The various areas that Jürgen K. Rockstroh examines in his Hepatitis C study include Chronic infection, Ribavirin, Hepatitis C virus and Public health.

His work deals with themes such as Ritonavir and Hepacivirus, which intersect with Ribavirin. The study incorporates disciplines such as Dolutegravir, Lamivudine and Randomized controlled trial in addition to Regimen. His research on Hepatocellular carcinoma also deals with topics like

  • Hepatitis B that connect with fields like Viral hepatitis,
  • Jaundice that connect with fields like Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

Edwin DeJesus;Jürgen K. Rockstroh;Keith Henry;Jean Michel Molina.
The Lancet (2012)

420 Citations

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.

Vincent Soriano;Mark Sulkowski;Colm Bergin;Angelos Hatzakis.
AIDS (2002)

400 Citations

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza.
The Lancet (2019)

371 Citations

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): A non-randomised, open-label trial

Jürgen K. Rockstroh;Mark Nelson;Christine Katlama;Jay Lalezari.
The Lancet HIV (2015)

344 Citations

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

Jan van Lunzen;Franco Maggiolo;José R Arribas;Aza Rakhmanova.
Lancet Infectious Diseases (2012)

326 Citations

Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution

Todd M. Allen;Marcus Altfeld;Shaun C. Geer;Elizabeth T. Kalife.
Journal of Virology (2005)

312 Citations

Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.

Luz Martín-Carbonero;Yves Benhamou;Massimo Puoti;Juan Berenguer.
Clinical Infectious Diseases (2004)

304 Citations

Variant of hepatitis B virus with primary resistance to adefovir

Oliver Schildgen;Hueseyin Sirma;Anneke Funk;Cynthia Olotu.
The New England Journal of Medicine (2006)

291 Citations

Care of patients with hepatitis C and HIV co-infection.

Vincent Soriano;Massimo Puoti;Mark Sulkowski;Stefan Mauss.
AIDS (2004)

283 Citations

Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials

Roy T. Steigbigel;David A. Cooper;Hedy Teppler;Joseph J. Eron.
Clinical Infectious Diseases (2010)

256 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jürgen K. Rockstroh

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 121

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 74

Pablo Barreiro

Pablo Barreiro

Hospital Universitario La Paz

Publications: 72

JK Rockstroh

JK Rockstroh

University Hospital Bonn

Publications: 70

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 62

Gregory J. Dore

Gregory J. Dore

UNSW Sydney

Publications: 61

Juan A. Pineda

Juan A. Pineda

Spanish National Research Council

Publications: 61

Gail V. Matthews

Gail V. Matthews

UNSW Sydney

Publications: 58

Marina B. Klein

Marina B. Klein

McGill University Health Centre

Publications: 56

Mark S. Sulkowski

Mark S. Sulkowski

Johns Hopkins University School of Medicine

Publications: 53

Christine Katlama

Christine Katlama

Université Paris Cité

Publications: 50

Caroline Sabin

Caroline Sabin

University College London

Publications: 49

Antonella d'Arminio Monforte

Antonella d'Arminio Monforte

University of Milan

Publications: 48

Dominique Costagliola

Dominique Costagliola

Université Paris Cité

Publications: 48

Matthias Cavassini

Matthias Cavassini

University of Lausanne

Publications: 47

Javier García-Samaniego

Javier García-Samaniego

Hospital Universitario La Paz

Publications: 47

Trending Scientists

Naresh R. Shanbhag

Naresh R. Shanbhag

University of Illinois at Urbana-Champaign

Yijun Liu

Yijun Liu

Southern University of Science and Technology

Masamichi Asukai

Masamichi Asukai

Sony (Japan)

Run-Wei Li

Run-Wei Li

Chinese Academy of Sciences

Jiaqiang Yan

Jiaqiang Yan

Oak Ridge National Laboratory

Sverre Heim

Sverre Heim

Oslo University Hospital

Rosie Woodroffe

Rosie Woodroffe

Zoological Society of London

E. van Heugten

E. van Heugten

North Carolina State University

Massimo Maffei

Massimo Maffei

University of Turin

Jean-Louis Carpentier

Jean-Louis Carpentier

University of Geneva

Guido Rubboli

Guido Rubboli

University of Copenhagen

Valentin Riedl

Valentin Riedl

Technical University of Munich

Robert L. Foote

Robert L. Foote

Mayo Clinic

Bert A. Rockman

Bert A. Rockman

Purdue University West Lafayette

J. W. Cronin

J. W. Cronin

University of Chicago

Something went wrong. Please try again later.